Related Experiment Video
Updated: Sep 28, 2026
Analysis of Histone Antibody Specificity with Peptide Microarrays
Published on: August 1, 2017
Various Anti-HSPA2 Antibodies Yield Different Results in Studies on Cancer-Related Functions of Heat Shock Protein A2
Dorota Scieglinska1, Damian Robert Sojka1, Agnieszka Gogler-Pigłowska1
1Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-101 Gliwice, Poland.
Abstract:
Heat shock proteins (HSPs) constitute a major part of the molecular chaperone system and play a fundamental role in cell proteostasis. The HSPA (HSP70) family groups twelve highly homologous HSPA proteins. Certain HSPAs are regarded as important cancer-related proteins, prospective therapeutic targets for cancer treatment, and also as potential cancer biomarkers. Heat Shock Protein A2 (HSPA2), a testis-enriched chaperone and one of the least characterized members of the HSPA family, has recently emerged as an important cancer-relevant protein with potential biomarker significance. Nevertheless, conflicting conclusions have been recently drawn both according to HSPA2 role in cancer cells, as well as to its prognostic value. In this work we have shown that one of the serious limitations in HSPA2 protein research is cross-reactivity of antibodies marketed as specific for HSPA2 with one or more other HSPA(s). Among non-specific antibodies were also those recently used for HSPA2 detection in functional and biomarker studies. We showed how using non-specific antibodies can generate misleading conclusions on HSPA2 expression in non-stressed cancer cells and tumors, as well as in cancer cells exposed to proteotoxic stress. Our findings addressed concerns on some published studies dealing with HSPA2 as a cancer-related protein.
Insights
Antibodies intended to detect Heat Shock Protein A2 (HSPA2) often cross-react with other proteins, leading to inaccurate cancer research findings. This study highlights antibody specificity issues impacting HSPA2
Area of Science:
- Molecular biology
- Cancer research
- Immunology
Background:
- Heat shock proteins (HSPs), particularly the HSPA (HSP70) family, are crucial for cellular proteostasis.
- Heat Shock Protein A2 (HSPA2) is implicated in cancer, but its role and biomarker potential are debated.
- Existing research on HSPA2 in cancer faces challenges due to conflicting conclusions.
Purpose of the Study:
- To investigate limitations in Heat Shock Protein A2 (HSPA2) research, specifically antibody cross-reactivity.
- To evaluate the impact of non-specific antibodies on HSPA2 expression studies in cancer.
- To address concerns regarding published findings on HSPA2's role in cancer.
Main Methods:
- Analysis of antibody specificity for Heat Shock Protein A2 (HSPA2).
- Assessment of HSPA2 detection in cancer cells and tumors using various antibodies.
- Evaluation of HSPA2 expression under normal and proteotoxic stress conditions.
Main Results:
- Antibodies marketed as HSPA2-specific exhibit cross-reactivity with other HSPA proteins.
- Non-specific antibodies lead to misleading conclusions about HSPA2 expression in cancer.
- Inaccurate HSPA2 detection affects studies on its role and prognostic value in cancer.
Conclusions:
- Antibody cross-reactivity is a significant limitation in HSPA2 research.
- Published findings on HSPA2 as a cancer-related protein may be compromised by unreliable antibodies.
- Ensuring antibody specificity is critical for accurate HSPA2 functional and biomarker studies in oncology.
